No Data
No Data
Special Pharmaceutical (002728.SZ): One of the Chinese herbal medicines used in cough medicine tablets is simply an extract extracted from poppy shell. Poppy shell is a nationally controlled medicinal herb, priced by the National Development and Reform Co
Gelonghui, April 24 | Teyi Pharmaceutical (002728.SZ) said on the investor interactive platform that one of the Chinese herbal medicines used in the company's cough medicine is simply an extract extracted from poppy shells. Poppy shell is a nationally controlled medicinal herb, and the price is set by the National Development and Reform Commission. In addition, the other raw materials needed for cough medicine tablets, such as aster, orange red, bellflower, citrus aurantium, and 100 parts, are all common Chinese herbal medicines on the market. The market supply is large, and there is no supply pressure. In addition, the company is equipped with a special warehouse for Chinese herbal medicines, so the company can make sufficient safe reserves according to subsequent market needs. Judging from the current level of consumption of Cough Remedies, Cough Remedies every day
Teyi Pharmaceutical (002728.SZ): The company holds approvals for drugs such as Qianbai rhinitis tablets, etc., and is currently not producing
On April 24, Gelonghui Pharmaceutical (002728.SZ) said on the investor interactive platform that the company holds pharmaceutical approvals for ketotifen fumarate tablets, chlorphenamine maleate tablets, nasal comfort tablets, and Qianbai rhinitis tablets, and are currently not producing them.
Teyi Pharmaceutical (002728.SZ): Net profit of 9.1546 million yuan in the first quarter decreased by 91.32% year on year
On April 19, Ge Longhui Pharmaceutical (002728.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 165 million yuan, down 45.88% year on year; net profit attributable to shareholders of listed companies was 9.1546 million yuan, down 91.32% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 8.924,600 yuan, down 91.51% year on year; basic earnings per share were 0.03 yuan.
We Wouldn't Be Too Quick To Buy Teyi Pharmaceutical Group Co.,Ltd (SZSE:002728) Before It Goes Ex-Dividend
Teyi Pharmaceutical Group Co.,Ltd (SZSE:002728) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one business day before the record date, which is the cut-off date for sharehold
Zhitong A Share Sale Restriction and Release List | April 11
According to the Zhitong Finance App, the ban on restricted shares of 9 listed companies was lifted on April 11, with a total market value of about 4.454 billion yuan. Today's specific sales restrictions and unbanned shares are as follows: Stock abbreviation, stock code, restricted stock type, number of banned shares, Sinoma International 600970, share incentives, 15.3612 million, Teyi Pharmaceutical 002728, original shareholder placement and listing 2014.65 million Xingyuan Material 300568 share incentives limited sale and circulation of 1,5309 million Huichuangda 300909 additional A-shares, corporate placement and listing of 1,50312 Wan Jiangyan Group 601065 shares restricted circulation before issuance
Teyi Pharmaceutical (002728.SZ): The ban on 2014.65 million restricted shares will be lifted on April 11
Gelonghui, April 8, 丨 Teyi Pharmaceutical (002728.SZ) announced an indicative announcement on the issuance of restricted shares to specific targets in 2023. The number of restricted shares lifted this time is 201465.14 million shares, accounting for 5.5235% of the company's total share capital at present. The current limited-sale stock listing circulation date is April 11, 2024 (Thursday).
No Data